Harmening Andrew J
Known title: President & CEOCIK: 0001705661
Harmening Andrew J's purchase track record
Harmening Andrew J has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/9/2025 | ASB | $300K | +4.5% | +12.3% | +18.9% |
| 3/9/2023 | ASB | $100K | -16.8% | -16.2% | +13.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ASB | ▼ Sell | Other | 2,516 | $76K | 9/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 2,554 | $75K | 6/15/2026 | View on chart |
| ASB | ▼ Sell | Other | 2,575 | $63K | 3/16/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 41,272 | $1.0M | 3/9/2026 | View on chart |
| ASB | ▲ Buy | Grant | 87,811 | $2.2M | 3/9/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 13,528 | $397K | 2/8/2026 | View on chart |
| ASB | ▲ Buy | Grant | 32,327 | $881K | 2/1/2026 | View on chart |
| ASB | ▼ Sell | Other | 2,189 | $59K | 12/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 2,145 | $56K | 9/15/2025 | View on chart |
| ASB | ▼ Sell | Other | 2,424 | $56K | 6/16/2025 | View on chart |
| ASB | ▲ Buy | Open Market | 12,910 | $300K | 5/9/2025 | View on chart |
| ASB | ▲ Buy | Grant | 71,982 | $1.5M | 3/10/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 33,832 | $726K | 3/10/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 12,746 | $321K | 2/10/2025 | View on chart |
| ASB | ▲ Buy | Grant | 28,305 | $0 | 1/29/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 39,840 | $859K | 4/26/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 20,863 | $432K | 3/13/2024 | View on chart |
| ASB | ▲ Buy | Grant | 44,389 | $919K | 3/13/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 9,182 | $183K | 2/9/2024 | View on chart |
| ASB | ▲ Buy | Grant | 30,592 | $0 | 1/30/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 39,840 | $710K | 5/1/2023 | View on chart |
| ASB | ▲ Buy | Open Market | 4,850 | $100K | 3/9/2023 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 5,695 | $136K | 2/9/2023 | View on chart |
| ASB | ▲ Buy | Grant | 29,314 | $0 | 1/30/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.